feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Indian Knees in Crisis: PRP & Stem Cells Under Scrutiny

Indian Knees in Crisis: PRP & Stem Cells Under Scrutiny

14 Jan

•

Summary

  • Knee degeneration affects younger Indians, driven by lifestyle and injuries.
  • PRP offers temporary pain relief for early knee issues, not cartilage repair.
  • Unproven stem cell therapies lack FDA approval for knee conditions.
Indian Knees in Crisis: PRP & Stem Cells Under Scrutiny

Knee problems are becoming more prevalent among younger and middle-aged Indians, moving beyond age-related osteoarthritis. Factors like obesity, lack of conditioning, and sports injuries contribute to chronic knee pain. Women, in particular, often experience knee issues earlier and more frequently due to hormonal changes post-menopause, weaker muscles, and delayed treatment seeking.

Regenerative treatments such as Platelet-Rich Plasma (PRP) injections and stem cell therapy are promoted as non-surgical solutions. However, orthopedic experts caution that PRP is effective for soft-tissue injuries but does not regenerate cartilage or reverse damage in osteoarthritis. Its benefits for knee arthritis are limited to temporary pain relief in early stages and are not recommended by major orthopedic associations for this condition.

Similarly, stem cell therapies offered in many Indian clinics often use unproven mixtures rather than lab-cultured cells. These treatments are experimental, lack US FDA approval for knee conditions, and offer no consistent long-term benefits. Reliable improvements for knee pain still stem from weight control, physiotherapy, muscle strengthening, and lifestyle modifications.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
PRP therapy uses a patient's own concentrated platelets, rich in growth factors, to reduce inflammation and aid healing, often providing temporary relief for early knee issues.
Current stem cell therapies offered commercially for knee osteoarthritis are experimental, lack US FDA approval, and have not proven effective in regenerating cartilage or bone.
While PRP may offer temporary pain relief for early knee osteoarthritis, it does not regenerate cartilage or reverse damage. For moderate to advanced stages, its effect is minimal.

Read more news on

Healthside-arrow
trending

Earthquake strikes western Turkiye

trending

Bangladesh ICC World Cup standoff

trending

Lauren Bell stuns at RCB

trending

Nipah virus outbreak in Bengal

trending

Infosys to hire graduates

trending

Grealish foot injury impacts Everton

trending

Tirumala prepares for Ratha Saptami

trending

Rani Mukerji Mardaani 3 release

trending

Jos Buttler T20 World Cup

You may also like

Abhay Deol's Stem Cell Journey for Pain Relief

8 hours ago • 2 reads

article image

Cancer Patients Fund Own Chemo Amid NHS Wait Woes

21 Dec, 2025 • 183 reads

article image

Scientists Engineer 'Super Soldiers' to Battle Cancer

9 Dec, 2025 • 215 reads

article image

Gene Therapy Cures "Bubble Boy Disease"

27 Nov, 2025 • 241 reads

article image

J&J's AAA Rating: A Dividend King's Stability

28 Nov, 2025 • 243 reads

article image